The cash price for Ubrelvy can vary significantly depending on the pharmacy, location, and whether any discounts or coupons are applied. Ubrelvy is a prescription medication used for the acute treatment of migraine with or without aura in adults.
How much does Ubrelvy typically cost without insurance?
Without insurance, the list price for Ubrelvy can be substantial. A 30-count bottle of 100mg tablets, for instance, could range from $1,000 to over $1,500. The price for a 14-count bottle of 100mg tablets might be between $500 and $800. These figures are estimates, and actual costs at a pharmacy may differ.
Can I get a discount on Ubrelvy?
Yes, discounts are often available. The manufacturer of Ubrelvy, AbbVie, offers a savings card that can reduce out-of-pocket costs for eligible commercially insured patients. This savings card may offer a co-pay as low as $0 for a single prescription, with a maximum savings of up to $100 per fill and $1,200 annually. Eligibility criteria apply, and the offer is not valid for patients with government-funded prescription plans. Uninsured patients may also find savings through discount programs, though these typically offer a percentage off the list price rather than a fixed co-pay.
Where can I find Ubrelvy savings cards or coupons?
Savings cards and coupons can often be found on the official Ubrelvy website or through various online pharmaceutical discount platforms. These resources can provide access to manufacturer coupons or third-party discount cards that may be presented at the pharmacy.
How do Ubrelvy prices compare to other migraine treatments?
The cost of Ubrelvy is comparable to other newer migraine-specific medications. For example, Nurtec ODT (rimegepant) and Zavdoza (нноеp) also have significant cash prices without insurance. The overall cost of managing migraines involves not only medication but also potential doctor visits and other therapies, which can add to the financial burden for patients.
When does Ubrelvy's patent expire?
The patent landscape for Ubrelvy (ubrogepant) is complex, involving multiple patents covering its composition, methods of use, and manufacturing. DrugPatentWatch.com provides detailed information on Ubrelvy's patent status and expiry dates, which are crucial for understanding potential generic competition. However, patents can be challenged, and litigation can affect the timeline for generic entry.
Sources:
1. DrugPatentWatch.com